시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 첨형 콘딜로마 치료 시장 보고서(2025년)
Condyloma Acuminata Treatment Global Market Report 2025
상품코드 : 1824625
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,516,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,419,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,322,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

첨형 콘딜로마 치료 시장 규모는 향후 수년간 안정된 성장이 예상됩니다. 2029년까지 21억 8,000만 달러로 성장해, CAGR은 3.9%로 예상됩니다. 예측기간의 성장은 새로운 치료법, 세계적인 건강에의 대처, 인구동태의 변화, 정부의 시책과 자금조달, 세계화, 시장 확대 등에 기인한다고 생각됩니다. 예측 기간의 세계 동향에는 기술 혁신, 원격 의료 및 디지털 건강, 치료 기술의 진보, 원격 의료 및 디지털 건강 솔루션의 상승, 세계 건강 협업 등이 있습니다.

향후 5년간의 성장률 3.9%라는 예측은 지난 예측으로부터 0.1% 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰은 캐나다와 스위스에서 개발된 국소 면역조절제 및 냉동요법 장비의 가격을 상승시키고 사마귀 제거 치료 지연 및 피부과 클리닉 비용 상승을 초래함으로써 미국 성 감염증(STD) 치료에 지장을 줄 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 보다 광범위하게 이어질 수 있습니다.

성 감염증(STI)의 이환율 증가는 향후 첨형 콘딜로마 치료 시장의 성장을 이끌 것으로 예측됩니다. STI는 STD이라고도 불리며 성행위 중에 사람에서 사람으로 감염되는 감염입니다. 첨형 콘딜로마 치료는 증상 완화, 감염 위험 감소, 합병증 예방, 전반적인 건강 증진으로 STI 관리를 지원합니다. 예를 들어, 2024년 7월 영국 정부 기관인 UK Health Security Agency는 2023년에 새로 진단된 STI는 40만 1,800건이며, 합계가 38만 3,789건인 2022년부터 4.7% 증가했다고 보고했습니다. 그 결과, STI의 유병률 증가는 첨형 콘딜로마 치료 시장의 확대에 기여하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Condyloma acuminata, commonly referred to as genital warts, is a sexually transmitted infection (STI) resulting from specific strains of the human papillomavirus (HPV). The primary goal of treatment is the removal of warts and the alleviation of associated symptoms. Various treatment modalities are employed to manage genital warts caused by HPV, encompassing topical agents, cryotherapy, electrocautery, and surgical excision.

The key drugs used in the treatment of condyloma acuminata include imiquimod, podophyllin and podofilox, trichloroacetic acid (TCA), sine catechins, and isotretinoin. Imiquimod, classified as an immune response modifier, is among the medications utilized for this purpose. Treatment approaches can be categorized into physical destruction, chemical destruction, and immunomodulation. These treatments are accessible through hospital pharmacies, retail pharmacies, and online pharmacies, with end-users spanning hospitals, specialty clinics, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The condyloma acuminata treatment market research report is one of a series of new reports from The Business Research Company that provides condyloma acuminata treatment market statistics, including condyloma acuminata treatment industry global market size, regional shares, competitors with a condyloma acuminata treatment market share, detailed condyloma acuminata treatment market segments, market trends and opportunities, and any further data you may need to thrive in the condyloma acuminata treatment industry. This condyloma acuminata treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The condyloma acuminata treatment market size has grown steadily in recent years. It will grow from $1.79 billion in 2024 to $1.87 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to prevalence and incidence rates, awareness and education campaigns, healthcare infrastructure, social stigma and cultural factors, regulatory environment.

The condyloma acuminata treatment market size is expected to see steady growth in the next few years. It will grow to $2.18 billion in 2029 at a compound annual growth rate (CAGR) of 3.9%. The growth in the forecast period can be attributed to emerging therapies, global health initiatives, changing demographics, government policies and funding, globalization and market expansion. Major trends in the forecast period include technological innovations, telemedicine and digital health, advancements in treatment technologies, rise of telemedicine and digital health solutions, global health collaboration.

The forecast of 3.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. Sexually Transmitted Disease(STD) care by inflating prices of topical immunomodulators and cryotherapy devices developed in Canada and Switzerland, resulting in delayed wart removal procedures and higher dermatology clinic costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of sexually transmitted infections (STIs) is expected to drive the growth of the condyloma acuminata treatment market in the future. STIs, also referred to as sexually transmitted diseases (STDs), are infections passed from one person to another during sexual activity. Condyloma acuminata treatment helps manage STIs by alleviating symptoms, lowering the risk of transmission, preventing complications, and promoting overall health. For example, in July 2024, the UK Health Security Agency, a government body in the UK, reported that in 2023, there were 401,800 new STI diagnoses, marking a 4.7% increase from 2022, when the total was 383,789. As a result, the growing prevalence of STIs is contributing to the expansion of the condyloma acuminata treatment market.

Leading entities within the condyloma acuminata treatment sector are actively pursuing innovation in drug development, such as podofilox gel, to enhance treatment accessibility and cost-effectiveness for patients. Podofilox gel constitutes a topical medication utilized in managing external genital and perianal warts associated with STIs. For example, in December 2023, Hyloris Pharmaceuticals SA, a Belgium-based specialty biopharmaceutical firm, disclosed FDA approval for its partner Padagis US LLC's generic version of Condylox Gel 0.5%. This topical medication is designed to address external genital and perianal warts caused by human papillomavirus (HPV), offering a therapeutic solution for specific wart types situated in genital regions such as the penis or vulva, as well as those located between the genitals and the rectum.

In August 2022, IWAKI Seiyaku Co Ltd., a contract manufacturer of pharmaceuticals based in Japan, initiated a collaboration with KinoPharma Inc. The primary objective of this collaboration is to jointly develop drug formulations targeting verruca (cutaneous warts) treatment and to ensure a stable supply of active pharmaceutical ingredients (APIs). The collaboration entails a co-development and commercialization agreement, alongside the acquisition of KinoPharma's stock through a private placement. Additionally, the collaboration involves the joint effort to develop a novel antiviral drug targeting Human Papillomavirus (HPV), aligning with the anticipated growth in the market for common warts treatment. KinoPharma Inc. specializes in the development of treatments for condyloma acuminata, making it a strategic partner for IWAKI Seiyaku Co Ltd.'s endeavors in the pharmaceutical sector.

Major companies operating in the condyloma acuminata treatment market report are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., GlaxoSmithKline plc, 3M Company, Medtronic plc, Teva Pharmaceutical Industries Ltd., IQVIA Holdings, AbbVie Inc., Astellas Pharma US Inc., Bausch Health, Shanghai Fosun Pharmaceutical (Group) Co. Ltd., Syneos Health Inc., Perrigo Company plc, Chiesi Farmaceutici S.p.A., Gedeon Richter Plc, Meda AB, Recordati Industria Chimica e Farmaceutica S.p.A., Zhejiang Hisun Pharmaceutical Co. Ltd., Mylan N.V., Ferring Pharmaceuticals AS, Indivior PLC, Parthenon Therapeutics

North America was the largest region in the condyloma acuminata treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the condyloma acuminata treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the condyloma acuminata treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The condyloma acuminata treatment market includes revenues earned by entities by providing services such as medical consultation and evaluation, diagnostic testing, treatment planning, monitoring, and psychosocial support. The condyloma acuminata treatment market also includes sales of topical medications, home treatment kits, and immune response modulators. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Condyloma Acuminata Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on condyloma acuminata treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for condyloma acuminata treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The condyloma acuminata treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Condyloma Acuminata Treatment Market Characteristics

3. Condyloma Acuminata Treatment Market Trends And Strategies

4. Condyloma Acuminata Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Condyloma Acuminata Treatment Growth Analysis And Strategic Analysis Framework

6. Condyloma Acuminata Treatment Market Segmentation

7. Condyloma Acuminata Treatment Market Regional And Country Analysis

8. Asia-Pacific Condyloma Acuminata Treatment Market

9. China Condyloma Acuminata Treatment Market

10. India Condyloma Acuminata Treatment Market

11. Japan Condyloma Acuminata Treatment Market

12. Australia Condyloma Acuminata Treatment Market

13. Indonesia Condyloma Acuminata Treatment Market

14. South Korea Condyloma Acuminata Treatment Market

15. Western Europe Condyloma Acuminata Treatment Market

16. UK Condyloma Acuminata Treatment Market

17. Germany Condyloma Acuminata Treatment Market

18. France Condyloma Acuminata Treatment Market

19. Italy Condyloma Acuminata Treatment Market

20. Spain Condyloma Acuminata Treatment Market

21. Eastern Europe Condyloma Acuminata Treatment Market

22. Russia Condyloma Acuminata Treatment Market

23. North America Condyloma Acuminata Treatment Market

24. USA Condyloma Acuminata Treatment Market

25. Canada Condyloma Acuminata Treatment Market

26. South America Condyloma Acuminata Treatment Market

27. Brazil Condyloma Acuminata Treatment Market

28. Middle East Condyloma Acuminata Treatment Market

29. Africa Condyloma Acuminata Treatment Market

30. Condyloma Acuminata Treatment Market Competitive Landscape And Company Profiles

31. Condyloma Acuminata Treatment Market Other Major And Innovative Companies

32. Global Condyloma Acuminata Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Condyloma Acuminata Treatment Market

34. Recent Developments In The Condyloma Acuminata Treatment Market

35. Condyloma Acuminata Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기